FindTrial
Sign In

The efficacy of hypotonic saline to reduce the recurrence of chronic subdural hematoma

The efficacy of hypotonic saline to reduce the recurrence of chronic subdural hematoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005740
Enrollment
166
Registered
2021-01-07
Start date
2017-03-29
Completion date
Unknown
Last updated
2021-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Soon Chun Hyang University Hospital Cheonan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who treated with the burr hole operation for symptomatic chronic subdural hematoma Who diagnosed the chronic subdural hematoma on brain CT or MRI normal platelet count and normal coagulation test who

Exclusion criteria

Exclusion criteria: 1. The patients who missed the chart record or radiologic record. 2. Below 18 years old 3. use of antiplatelets (ticagrelor, prasugrel) or anticoagulant after admission 4. who had severe pulmonary edema, liver cirrhosis, systemic generalized edema 5. When the investigator determines that participation in the clinical trial is inappropriate because it may affect other ethical or clinical trial results

Design outcomes

Primary

MeasureTime frame
recurrence of chronic subdural hematoma;disappearance of symptoms from chronic subdural hematoma—

Secondary

MeasureTime frame
isappearance of chronic subdural hematoma on brain image—

Countries

Korea, Republic of

Contacts

Public ContactJae sang Oh

Soon Chun Hyang University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026